HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Smith-Jones Selected Research

2- (4- iodophenylamino)pyrido(2,3- d)pyrimidin- 7- one

1/2010(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Smith-Jones Research Topics

Disease

16Neoplasms (Cancer)
03/2016 - 04/2005
3Prostatic Neoplasms (Prostate Cancer)
03/2012 - 11/2003
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2011 - 01/2010
2Hypoxia (Hypoxemia)
09/2015 - 04/2005
2Neoplasm Metastasis (Metastasis)
02/2011 - 05/2010
2Neuroblastoma
05/2010 - 06/2008
1Tuberculosis (Tuberculoses)
01/2017
1Lymphoma (Lymphomas)
03/2016
1Pulmonary Hypertension
09/2015
1Glioblastoma (Glioblastoma Multiforme)
12/2012
1Brain Neoplasms (Brain Tumor)
12/2012
1Glioma (Gliomas)
12/2012
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
08/2011
1Vascular Remodeling
11/2010
1Ovarian Neoplasms (Ovarian Cancer)
10/2010
1Bone Resorption
08/2008
1Pheochromocytoma
06/2008
1Sialadenitis
06/2008
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2007

Drug/Important Bio-Agent (IBA)

5Pharmaceutical PreparationsIBA
01/2017 - 01/2011
5AntigensIBA
10/2015 - 11/2003
4Proteins (Proteins, Gene)FDA Link
03/2016 - 10/2010
3Liposomes (Liposome)IBA
02/2015 - 01/2011
3Phosphotransferases (Kinase)IBA
08/2011 - 01/2010
26- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA
03/2016 - 09/2011
2Monoclonal AntibodiesIBA
10/2015 - 11/2003
2LipidsIBA
02/2015 - 02/2011
2AntibodiesIBA
05/2010 - 10/2007
1PyrazinamideFDA LinkGeneric
01/2017
1purineIBA
03/2016
1Adenosine Triphosphate (ATP)IBA
03/2016
1Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2016
1Molecular Chaperones (Chaperone, Molecular)IBA
03/2016
1Neoplasm Antigens (Tumor Antigens)IBA
10/2015
1Glucose (Dextrose)FDA LinkGeneric
09/2015
1Fatty Acids (Saturated Fatty Acids)IBA
09/2015
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2015
1Semaxinib (SU5416)IBA
09/2015
1IndiumIBA
01/2015
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
12/2012
1Dasatinib (BMS 354825)FDA Link
12/2012
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
12/2012
1Biological ProductsIBA
12/2012
1FluorineIBA
12/2012
1MicellesIBA
12/2012
1Androgen Antagonists (Antiandrogens)IBA
03/2012
1apalutamideIBA
03/2012
1Androgen Receptors (Androgen Receptor)IBA
03/2012
1ProteomeIBA
09/2011
1Oncogene Proteins (Oncogene Protein)IBA
09/2011
1Imatinib Mesylate (Gleevec)FDA Link
08/2011
1ErbB Receptors (EGF Receptor)IBA
02/2011
1LigandsIBA
01/2011
1GelatinasesIBA
01/2011
1E4G10 antibodyIBA
11/2010
1cadherin 5IBA
11/2010
1MucinsIBA
10/2010
12- (4- iodophenylamino)pyrido(2,3- d)pyrimidin- 7- oneIBA
01/2010
1Diphosphonates (Bisphosphonates)IBA
08/2008
13-Iodobenzylguanidine (Iobenguane)IBA
06/2008
1Hu3S193 monoclonal antibodyIBA
10/2007
1Blood Group Antigens (Blood Groups)IBA
10/2007
1AndrogensIBA
10/2005
1fluoromisonidazoleIBA
04/2005
1copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA
04/2005
1Hormones (Hormone)IBA
11/2003
1J591 monoclonal antibodyIBA
11/2003

Therapy/Procedure

7Therapeutics
10/2015 - 06/2008
3Radioimmunotherapy
02/2011 - 11/2003
3Drug Therapy (Chemotherapy)
11/2010 - 10/2007
1Castration
03/2012
1Craniospinal Irradiation
05/2010
1Aftercare (After-Treatment)
01/2010
1Arthroplasty
08/2008
1Immunotherapy
10/2007
1Gamma Cameras (Gamma Camera)
11/2003